A Trial of AMG 479, Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer - QUILT-3.007

NCT01061788 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumors, Non-small Cell Lung Cancer

Interventions

DRUG: AMG 479, Everolimus, Panitumumab

Sponsor

Jeffrey Clarke

Collaborators

[object Object]
[object Object]